BioStock: BrainCool’s CEO on the purchase agreement in the US

BrainCool has signed a purchase agreement for IQool System with Vanderbilt Health in the US. The aim is to make the medical device available in the 74 hospitals that are part of that health system. BioStock talked to BrainCool’s CEO Martin Waleij about the agreement and its potential commercial benefits.

Read the full interview with Martin Waleij at biostock.se:

https://www.biostock.se/en/2023/05/braincools-ceo-on-the-purchase-agreement-in-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/